Skip to main content

Home/ PHE - Resources/ Group items tagged precision-medicine

Rss Feed Group items tagged

Dennis OConnor

Qualifying and quantifying the precision medicine rhetoric - 0 views

  •  
    Background With the rise of precision medicine efforts worldwide, our study objective was to describe and map the emerging precision medicine landscape. A Google search was conducted between June 19, 2017 to July 20, 2017 to examine how "precision medicine" and its analogous terminology were used to describe precision medicine efforts. Resulting web-pages were reviewed for geographic location, data type(s), program aim(s), sample size, duration, and the key search terms used and recorded in a database. Descriptive statistics were applied to quantify terminology used to describe specific precision medicine efforts. Qualitative data were analyzed for content and patterns.
Dennis OConnor

precision medicine at stanford medicine x - 0 views

  •  
    "Medicine X is Stanford University's premier health care innovation program focusing on the intersection of emerging technologies and medicine. Our initiative is a catalyst for new ideas, and explores how we can work together to advance the practice of medicine, implement new approaches to healthcare such as precision medicine, and empower all stakeholders to be active participants in discussions about the future of health care. Under the direction of Dr. Larry Chu, Associate Professor of Anesthesia at Stanford School of Medicine, and guided by the Everyone Included™ framework for co-creation and leadership, Medicine X is a project of the Stanford AIM Lab and a growing international community."
Dennis OConnor

PMLS 2019 WEST - Precision Medicine Leaders Summit - 0 views

  •  
    "Building on the successes of our events in Philadelphia and Jersey City, we are excited to be back where it all began - San Diego.  Please join us for the most thought-provoking Precision Medicine event in the marketplace. Our speakers cover the panoply of leaders in the healthcare continuum, these include clinicians, industry experts, academics, regulators, payers, genetic counselors, bioinformaticians, and many more who are shaping the way Precision Medicine is implemented into healthcare systems on a global scale. Join us for panel discussions, keynotes, "Meet the Expert", roundtables, networking, exhibits, and opening reception to hear from thought leaders who are making the promise of Precision Medicine a reality. "
Dennis OConnor

UnDx Consortium - 0 views

  •  
    The UnDx Consortium The UnDx Consortium™ is an initiative of precision medicine technology companies and scientists to explore how a multidisciplinary approach to precision medicine can provide information and answers for patients with undiagnosed diseases. is an initiative of precision medicine technology companies and scientists to explore how a multidisciplinary approach to precision medicine can provide information and answers for patients with undiagnosed diseases.
Dennis OConnor

Patient Information | Center for Applied Genomics & Precision Medicine - 1 views

  •  
    Recommended by: DeAunne Denmark, MD, PhD "It's important for the public to be aware of what's available to them in the world of genomics and precision medicine. Various resources are available that provide general and disease-specific information about genomics and precision medicine. A list of some resources available to the public is provided below, but additional resources are likely available through your health provider or other groups such as the US National Institutes of Health."
  •  
    The resource index in this article is incredible.
Dennis OConnor

Early data suggests wearables can flag some Covid-19 cases early - 1 views

  •  
    "Although each effort is being conducted separately, all of the studies center around a common principle that by establishing a baseline set of biometrics for every study participant - including temperature, heart rate, and activity and sleep levels - researchers can detect deviations that are suggestive of illness." "Forget precision medicine. This is precision health," said Michael Snyder, Stanford University School of Medicine genetics department chair and director of genomics and personalized medicine.
Dennis OConnor

Fairness in Precision Medicine | Data & Society - 1 views

  •  
    ""Excitement for precision medicine must be matched with clear-eyed examinations of the possibility for this emerging field to exacerbate existing risks…or create new points of vulnerability.""
Dennis OConnor

Precision medicine: Opening the aperture | McKinsey - 0 views

  •  
    "To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models."
Dennis OConnor

Speeches by FDA Officials > Blueprint for Breakthroughs - Charting the Course for Preci... - 1 views

  •  
    "Remarks by Scott Gottlieb, M.D. Commissioner of Food and Drugs Friends of Cancer Research 7th Annual Blueprint for Breakthrough Forum Sept. 13, 2018 Washingon, DC "Blueprint for Breakthroughs - Charting the Course for Precision Medicin"
Dennis OConnor

Why we need a small data paradigm | BMC Medicine | Full Text - 0 views

  •  
    "There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit."
Dennis OConnor

Genes, Blood Type Tied to Risk of Severe COVID-19 - NIH Director's Blog - 0 views

  • Many people who contract COVID-19 have only a mild illness, or sometimes no symptoms at all. But others develop respiratory failure that requires oxygen support or even a ventilator to help them recover [1]. It’s clear that this happens more often in men than in women, as well as in people who are older or who have chronic health conditions. But why does respiratory failure also sometimes occur in people who are young and seemingly healthy? A new study suggests that part of the answer to this question may be found in the genes that each one of us carries [2]. While more research is needed to pinpoint the precise underlying genes and mechanisms responsible, a recent genome-wide association (GWAS) study, just published in the New England Journal of Medicine, finds that gene variants in two regions of the human genome are associated with severe COVID-19 and correspondingly carry a greater risk of COVID-19-related death.
  • the findings suggest that people with blood type A face a 50 percent greater risk of needing oxygen support or a ventilator should they become infected with the novel coronavirus.
  • Their study included 1,980 people undergoing treatment for severe COVID-19 and respiratory failure at seven medical centers in Italy and Spain.
  • ...4 more annotations...
  • the researchers compared SNPs in people with severe COVID-19 to those in more than 1,200 healthy blood donors from the same population groups.
  • he researchers did find evidence suggesting a relationship between blood type and COVID-19 risk. They noted that this area also includes a genetic variant associated with increased levels of interleukin-6, which plays a role in inflammation and may have implications for COVID-19 as well.
  • T
  • Franke, Karlsen, and many of their colleagues are part of the COVID-19 Host Genetics Initiative, an ongoing international collaborative effort to learn the genetic determinants of COVID-19 susceptibility, severity, and outcomes
  •  
    "Many people who contract COVID-19 have only a mild illness, or sometimes no symptoms at all. But others develop respiratory failure that requires oxygen support or even a ventilator to help them recover [1]. It's clear that this happens more often in men than in women, as well as in people who are older or who have chronic health conditions. But why does respiratory failure also sometimes occur in people who are young and seemingly healthy? A new study suggests that part of the answer to this question may be found in the genes that each one of us carries [2]. While more research is needed to pinpoint the precise underlying genes and mechanisms responsible, a recent genome-wide association (GWAS) study, just published in the New England Journal of Medicine, finds that gene variants in two regions of the human genome are associated with severe COVID-19 and correspondingly carry a greater risk of COVID-19-related death."
Dennis OConnor

Tempus Data-driven precision medicine - 0 views

  •  
    Tempus is making precision medicine a reality. Through the power of artificial intelligence, we believe all patients will eventually be on their own personalized diagnostic and therapeutic path. With the world's largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitate discovery, development and delivery of optimized therapeutic options for patients through distinctive solution sets.
Dennis OConnor

(4) Can Precision Health Transform Primary Care? Look to Stanford's Humanwide Pilot. | ... - 0 views

  •  
    "For each patient, the Humanwide care team carefully documented factors that we know influence health, but which often aren't incorporated into primary care today, including stress levels, sleep habits, and environmental exposures. Patients also received genetic screenings and pharmacogenomic testing (which looks at a patient's genes to predict how they will react to a variety of medicines). In addition, each patient was given four digital health devices-a pedometer, a digital scale, a blood pressure cuff, and a glucometer to measure blood sugar-to track and measure their health and progress throughout their daily lives. All of this data was fed into patients' electronic health records and discussed at regular check-ins with their physicians."
Dennis OConnor

UC San Diego receives $14m to drive precision nutrition - 0 views

  •  
    "The Nutrition for Precision Health consortium includes $14.55 million to launch a new Microbiome and Metagenomics Center at UC San Diego. The center will analyze the microbiomes - communities of microbes and their genetic material - found in the stool samples of nutrition study participants. "
Dennis OConnor

UnDx Consortium - U N D I A G N O S E D - 0 views

  •  
    "The UnDx Consortium™ is an initiative of precision medicine technology companies and scientists to explore how a multidisciplinary approach to precision medicine can provide information and answers for patients with undiagnosed diseases. "
Dennis OConnor

National Institutes of Health (NIH) - All of Us - 0 views

  •  
    "The future of health begins with you The All of Us Research Program is a historic effort to gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, environment, and biology, researchers will uncover paths toward delivering precision medicine."
Dennis OConnor

The expanding landscape of consumer genetic health testing - Precision Medicine Advisors - 0 views

  •  
    Recommended by DeAunne Denmark, MD, PhD: "Consumer genetic testing for health conditions has always been viewed with some skepticism by healthcare professionals. For many, direct-to-consumer (DTC) genetic testing was synonymous with 23andMe, whose health-related products are perceived as having little to no value for health care. But the landscape for consumer-initiated genetic health testing has changed dramatically in just the last year."
Dennis OConnor

PMWC 2021 COVID-19 Conference Jan. 25-27 - Prec. Med. World Conf. - 1 views

  •  
    The COVID-19 pandemic makes it necessary for leading experts from across disciplines and geographies to come together to jointly address the challenges we are facing when coping with the disruptive nature of the coronavirus SARS-CoV-2 pandemic is having on our healthcare system and our society as a whole. The tasks upon us are enormous and include besides decoding the virus and scaling diagnostics, tackling COVID-19 within existing healthcare systems, building health data platforms that support COVID-19 focused health care, accommodating clinical trials in the era of COVID-19, and developing functional vaccines and therapeutics. The next PMWC 2021 on January 25-27 would be a virtual conference and will touch upon these critical developments and ongoing activities while also including the regulatory and investment sides that influence clinical advancements.
Dennis OConnor

Reimagine Brain Health - YouTube - 0 views

  •  
    Our 2020 virtual Reimagine event highlighted ISB's cutting-edge brain health research and our unique approach to studying and treating Alzheimer's and other diseases. Specifically, we featured some of our latest findings, the promise of multimodal therapies to slow and even reverse dementia, and testimony from caregivers who watched their loved ones succumb to Alzheimer's disease.
1 - 20 of 20
Showing 20 items per page